<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6734224</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">30995925</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">6734224</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">982</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1186/s10194-019-0982-3</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics of the CADASIL and control groups</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p>Demographic and clinical characteristics of the CADASIL and control groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>CADASIL group (<italic>n</italic> = 22)</th><th>Control group (<italic>n</italic> = 44)</th><th><italic>p-</italic>values</th></tr></thead><tbody><tr><td>Male/Female</td><td>13/9</td><td>26/18</td><td>1</td></tr><tr><td>Age at visit (years)</td><td>49.0 ± 14.2</td><td>48.5 ± 13.7</td><td>0.873</td></tr><tr><td>Family history, n (%)</td><td>19 (86.4)</td><td>-</td><td>-</td></tr><tr><td>Age at first symptom (years)</td><td>45.7 ± 13.3</td><td>-</td><td>-</td></tr><tr><td>Previous stroke or TIA (times)</td><td>1.7 ± 2.7</td><td>-</td><td>-</td></tr><tr><td>Vascular disease risk factors, n (%)</td><td>10 (45.5)</td><td>-</td><td>-</td></tr><tr><td>Headache, n (%)</td><td>3 (13.6)</td><td>-</td><td>-</td></tr><tr><td>Fazekas score</td><td>2.1 ± 1.2</td><td>-</td><td>-</td></tr><tr><td>MMSE</td><td>23.3 ± 6.3</td><td>28.6 ± 1.1</td><td>0.001</td></tr><tr><td>MoCA</td><td>20.7 ± 7.9</td><td>27.9 ± 1.4</td><td>0.000</td></tr><tr><td>HAMD</td><td>7.0 ± 7.1</td><td>4.0 ± 1.8</td><td>0.067</td></tr><tr><td>HAMA</td><td>5.9 ± 6.0</td><td>3.7 ± 1.6</td><td>0.108</td></tr><tr><td>NIHSS</td><td>1.2 ± 1.9</td><td>-</td><td>-</td></tr><tr><td>mRs</td><td>1.3 ± 1.2</td><td>-</td><td>-</td></tr></tbody></table><table-wrap-foot><p>Values are mean ± standard deviation (SD) or numbers and percentages. <italic>CADASIL</italic> cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, <italic>MMSE</italic> Mini-Mental State Examination, <italic>MoCA</italic> Montreal Cognitive Assessment, <italic>HAMD</italic> Hamilton Depression Scale, <italic>HAMA</italic> Hamilton Anxiety Scale, <italic>NIHSS</italic> National Institute of Health Stroke <italic>Scale</italic>, mRs modified Rankin scale, <italic>SD</italic> standard deviation, <italic>TIA</italic> transient ischemic attack</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of the CADASIL and control groups</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>CADASIL group (n = 22)</th><th>Control group (n = 44)</th><th>p-values</th></tr></thead><tbody><tr><td>Male/Female</td><td>13/9</td><td>26/18</td><td>1</td></tr><tr><td>Age at visit (years)</td><td>49.0 ± 14.2</td><td>48.5 ± 13.7</td><td>0.873</td></tr><tr><td>Family history, n (%)</td><td>19 (86.4)</td><td>-</td><td>-</td></tr><tr><td>Age at first symptom (years)</td><td>45.7 ± 13.3</td><td>-</td><td>-</td></tr><tr><td>Previous stroke or TIA (times)</td><td>1.7 ± 2.7</td><td>-</td><td>-</td></tr><tr><td>Vascular disease risk factors, n (%)</td><td>10 (45.5)</td><td>-</td><td>-</td></tr><tr><td>Headache, n (%)</td><td>3 (13.6)</td><td>-</td><td>-</td></tr><tr><td>Fazekas score</td><td>2.1 ± 1.2</td><td>-</td><td>-</td></tr><tr><td>MMSE</td><td>23.3 ± 6.3</td><td>28.6 ± 1.1</td><td>0.001</td></tr><tr><td>MoCA</td><td>20.7 ± 7.9</td><td>27.9 ± 1.4</td><td>0.000</td></tr><tr><td>HAMD</td><td>7.0 ± 7.1</td><td>4.0 ± 1.8</td><td>0.067</td></tr><tr><td>HAMA</td><td>5.9 ± 6.0</td><td>3.7 ± 1.6</td><td>0.108</td></tr><tr><td>NIHSS</td><td>1.2 ± 1.9</td><td>-</td><td>-</td></tr><tr><td>mRs</td><td>1.3 ± 1.2</td><td>-</td><td>-</td></tr></tbody></table></div>Values are mean ± standard deviation (SD) or numbers and percentages. CADASIL cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, HAMD Hamilton Depression Scale, HAMA Hamilton Anxiety Scale, NIHSS National Institute of Health Stroke Scale, mRs modified Rankin scale, SD standard deviation, TIA transient ischemic attack</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Significant inter-group differences in ALFF among CADASIL and controls</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table 2</label><caption><p>Significant inter-group differences in ALFF among CADASIL and controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Predominant regions in cluster</th><th>Cluster size</th><th>Peak <italic>T</italic> value</th><th colspan="3">MNI coordinates</th><th>Cluster level <italic>P</italic><sub>FWE-corr</sub></th></tr><tr><th/><th/><th/><th>x</th><th>y</th><th>z</th><th/></tr></thead><tbody><tr><td colspan="7">ALFF reduction in CADASIL</td></tr><tr><td> Right Pcu/CU (BA 7/BA 17)</td><td>210</td><td>−5.31</td><td>6</td><td>− 81</td><td>30</td><td>0.000</td></tr><tr><td colspan="7">ALFF increase in CADASIL</td></tr><tr><td> Left SFG (BA 10)</td><td>88</td><td>5.28</td><td>−12</td><td>60</td><td>3</td><td>0.008</td></tr><tr><td> Right SFG (BA 10)</td><td>62</td><td>4.82</td><td>21</td><td>60</td><td>− 6</td><td>0.034</td></tr><tr><td> Left cerebellar anterior and posterior lobes</td><td>58</td><td>4.38</td><td>−9</td><td>− 51</td><td>− 36</td><td>0.044</td></tr></tbody></table><table-wrap-foot><p>The surviving clusters of ALFF were assigned thresholds of <italic>p</italic> &lt; 0.001 and FWE-corrected to <italic>p</italic> &lt; 0.05 at the cluster level</p><p><italic>ALFF</italic> amplitude of low-frequency fluctuation, <italic>CADASIL</italic> cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, <italic>Pcu/CU</italic> precuneus and cuneus, <italic>SFG</italic> superior frontal gyrus, <italic>BA</italic> Brodmann’s area, <italic>MNI</italic> Montreal Neurological Institute</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Significant inter-group differences in ALFF among CADASIL and controls</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Predominant regions in cluster</th><th>Cluster size</th><th>Peak T value</th><th colspan="3">MNI coordinates</th><th>Cluster level PFWE-corr</th></tr><tr><th/><th/><th/><th>x</th><th>y</th><th>z</th><th/></tr></thead><tbody><tr><td colspan="7">ALFF reduction in CADASIL</td></tr><tr><td> Right Pcu/CU (BA 7/BA 17)</td><td>210</td><td>−5.31</td><td>6</td><td>− 81</td><td>30</td><td>0.000</td></tr><tr><td colspan="7">ALFF increase in CADASIL</td></tr><tr><td> Left SFG (BA 10)</td><td>88</td><td>5.28</td><td>−12</td><td>60</td><td>3</td><td>0.008</td></tr><tr><td> Right SFG (BA 10)</td><td>62</td><td>4.82</td><td>21</td><td>60</td><td>− 6</td><td>0.034</td></tr><tr><td> Left cerebellar anterior and posterior lobes</td><td>58</td><td>4.38</td><td>−9</td><td>− 51</td><td>− 36</td><td>0.044</td></tr></tbody></table></div>The surviving clusters of ALFF were assigned thresholds of p &lt; 0.001 and FWE-corrected to p &lt; 0.05 at the cluster levelALFF amplitude of low-frequency fluctuation, CADASIL cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, Pcu/CU precuneus and cuneus, SFG superior frontal gyrus, BA Brodmann’s area, MNI Montreal Neurological Institute</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Significant inter-group differences in the FC analysis of patients with CADASIL and controls</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table 3</label><caption><p>Significant inter-group differences in the FC analysis of patients with CADASIL and controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Predominant regions in cluster</th><th>Cluster size</th><th>Peak <italic>T</italic> value</th><th colspan="3">MNI coordinates</th><th>Cluster level <italic>P</italic><sub>FWE-corr</sub></th></tr><tr><th/><th/><th/><th>x</th><th>y</th><th>z</th><th/></tr></thead><tbody><tr><td colspan="7">CADASIL &lt; controls (seed region: left SFG)</td></tr><tr><td> Right precentral gyrus</td><td>116</td><td>−3.78</td><td>60</td><td>− 6</td><td>36</td><td>0.037</td></tr><tr><td> Bilateral pons</td><td>115</td><td>−4.79</td><td>12</td><td>− 18</td><td>− 33</td><td>0.038</td></tr><tr><td colspan="7">CADASIL &lt; controls (seed region: right SFG)</td></tr><tr><td> Right precentral gyrus</td><td>239</td><td>−4.14</td><td>48</td><td>9</td><td>39</td><td>0.001</td></tr><tr><td> Left postcentral gyrus</td><td>133</td><td>− 4.48</td><td>− 51</td><td>− 21</td><td>39</td><td>0.020</td></tr><tr><td colspan="7">CADASIL &lt; controls (seed region: right Pcu/CU)</td></tr><tr><td> Right cuneus</td><td>239</td><td>−5.42</td><td>6</td><td>−87</td><td>36</td><td>0.002</td></tr><tr><td> Right PHG</td><td>184</td><td>− 5.35</td><td>24</td><td>−27</td><td>−3</td><td>0.007</td></tr><tr><td colspan="7">CADASIL compared to controls (seed region: left cerebellar anterior and posterior lobes)</td></tr><tr><td> Right pon</td><td>109</td><td>−4.93</td><td>9</td><td>−18</td><td>− 33</td><td>0.057</td></tr><tr><td> Left cerebrum</td><td>31</td><td>−3.84</td><td>−24</td><td>−15</td><td>− 3</td><td>0.519</td></tr></tbody></table><table-wrap-foot><p>The surviving clusters of FC were assigned thresholds at <italic>p</italic> &lt; 0.001 and FWE-</p><p>corrected to <italic>p</italic> &lt; 0.05 at the cluster level</p><p><italic>FC</italic> functional connectivity, <italic>CADASIL</italic> cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, <italic>SFG</italic> superior frontal gyrus, <italic>Pcu/CU</italic> precuneus and cuneus, <italic>PHG</italic> parahippocampal gyrus, <italic>MNI</italic> Montreal Neurological Institute</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Significant inter-group differences in the FC analysis of patients with CADASIL and controls</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Predominant regions in cluster</th><th>Cluster size</th><th>Peak T value</th><th colspan="3">MNI coordinates</th><th>Cluster level PFWE-corr</th></tr><tr><th/><th/><th/><th>x</th><th>y</th><th>z</th><th/></tr></thead><tbody><tr><td colspan="7">CADASIL &lt; controls (seed region: left SFG)</td></tr><tr><td> Right precentral gyrus</td><td>116</td><td>−3.78</td><td>60</td><td>− 6</td><td>36</td><td>0.037</td></tr><tr><td> Bilateral pons</td><td>115</td><td>−4.79</td><td>12</td><td>− 18</td><td>− 33</td><td>0.038</td></tr><tr><td colspan="7">CADASIL &lt; controls (seed region: right SFG)</td></tr><tr><td> Right precentral gyrus</td><td>239</td><td>−4.14</td><td>48</td><td>9</td><td>39</td><td>0.001</td></tr><tr><td> Left postcentral gyrus</td><td>133</td><td>− 4.48</td><td>− 51</td><td>− 21</td><td>39</td><td>0.020</td></tr><tr><td colspan="7">CADASIL &lt; controls (seed region: right Pcu/CU)</td></tr><tr><td> Right cuneus</td><td>239</td><td>−5.42</td><td>6</td><td>−87</td><td>36</td><td>0.002</td></tr><tr><td> Right PHG</td><td>184</td><td>− 5.35</td><td>24</td><td>−27</td><td>−3</td><td>0.007</td></tr><tr><td colspan="7">CADASIL compared to controls (seed region: left cerebellar anterior and posterior lobes)</td></tr><tr><td> Right pon</td><td>109</td><td>−4.93</td><td>9</td><td>−18</td><td>− 33</td><td>0.057</td></tr><tr><td> Left cerebrum</td><td>31</td><td>−3.84</td><td>−24</td><td>−15</td><td>− 3</td><td>0.519</td></tr></tbody></table></div>The surviving clusters of FC were assigned thresholds at p &lt; 0.001 and FWE-corrected to p &lt; 0.05 at the cluster levelFC functional connectivity, CADASIL cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, SFG superior frontal gyrus, Pcu/CU precuneus and cuneus, PHG parahippocampal gyrus, MNI Montreal Neurological Institute</transformed-table></extracted-table></extracted-tables-set>